We now have to change the way we classify, diagnose and treat neuropathic pain from an etiology-based to a mechanism-based approach. In clinical practice, the diagnostic work-up should aim at ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...

"Ketamir-2's unique mechanism and pharmacological profile make it a highly promising candidate for neuropathic pain. If successful, it could represent a safer, non-addictive alternative to opioids ...

Neuropathic pain can occur after severe injuries and ... Algiax's candidate offers a new potential mechanism of action for pain relief, and is thought to work by correcting excessive activation ...

Its exact mechanism of action is unknown ... The starting dosage for patients with neuropathic pain associated with diabetic peripheral neuropathy is 50 mg three times daily and may be increased ...

This unique mechanism is believed to contribute to ... has granted Fast Track designation to AV-101 for the treatment of ...

Vertex is also exploring the potential of suzetrigine in treating peripheral neuropathic pain ... The therapy’s mechanism ...